New nasal COVID booster vaccine enters human testing
NCT ID NCT07536308
First seen Apr 19, 2026 · Last updated May 07, 2026 · Updated 3 times
Summary
This early-stage study tests a new booster vaccine called OCU500, designed to protect against COVID-19. Unlike a shot, it is given as a nasal spray or inhaler. The study involves 80 healthy adults aged 18-64 who have already received a primary COVID-19 vaccine series and at least one booster. The main goal is to check the vaccine's safety and how well it triggers an immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID - 19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
NOT_YET_RECRUITINGBoston, Massachusetts, 02115-6110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Hope Clinic of Emory University
NOT_YET_RECRUITINGDecatur, Georgia, 30030-1705, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
RECRUITINGBaltimore, Maryland, 21201-1509, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Medical Branch
NOT_YET_RECRUITINGGalveston, Texas, 77555-0435, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University School of Medicine in St. Louis - Infectious Disease Clinical Research Unit
WITHDRAWNSt Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.